首页> 美国卫生研究院文献>The Journal of Clinical Investigation >Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways.
【2h】

Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways.

机译:威廉姆斯特质。人激肽原缺乏症纤溶酶原激活剂和激肽释放酶水平降低与Hageman因子依赖性途径异常相关。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

An asymptomatic woman (Ms. Williams) was found to have a severe abnormality in the surface-activated intrinsic coagulation, fibrinolytic, and kinin-generating pathways. Assays for known coagulation factors were nromal while Fletcher factor (pre-kallikrein) was 45%, insufficient to account for the observed markedly prolonged partial thromboplastin time. Plasminogen proactivator was present at 20% of normal levels and addition of highly purified plasminogen proactivator containing 10% plasminogen activator partially corrected the coagulation and fibrinolytic abnormalities but not the kinin-generating defect. This effect was due to its plasminogen activator content. In addition, Williams trait plasma failed to convert prekallilrein to lakkilrein or release kinin upon incubation with kaolin. Kininogen antigen was undetectable. When normal plasma was fractionated to identify the factor that corrects all the abnormalities in Williams trait plasma, the Williams factor was identified as a form of kininogen by its behavior on ion exchange chromatography, gel filtration, disc gel electrophoresis, and elution from an anti-low molecular weight kininogen immunoadsorbent. High molecular weight kininogen as well as a subfraction of low molecular weight kininogen, possessed this corrective activity while the bulk of low molecular weight kininogen functioned only as a kallikrein substrate. Kininogen therefore is a critical factor required for the functioning of Hageman factor-dependent coagulation and fibrinolysis and for the activation of prekallikrein.
机译:无症状妇女(威廉姆斯女士)被发现在表面激活的内在凝血,纤溶和激肽生成途径中存在严重异常。已知凝血因子的测定为组蛋白,而弗莱彻因子(激肽释放酶原)为45%,不足以说明观察到的部分凝血活酶时间明显延长。纤溶酶原激活剂的含量为正常水平的20%,添加高纯度的纤溶酶原激活剂(含10%纤溶酶原激活剂)可部分纠正凝血和纤溶异常,但不能纠正激肽生成缺陷。该作用归因于其纤溶酶原激活剂的含量。此外,威廉姆斯性状血浆在与高岭土一起孵育后未能将普瑞卡瑞林转化为乐凯瑞林或释放激肽。激肽原抗原未检测到。当对正常血浆进行分级分离以鉴定纠正Williams性状血浆中所有异常的因素时,Williams因子通过其在离子交换色谱,凝胶过滤,盘式凝胶电泳以及从抗血红蛋白洗脱中的行为而被鉴定为激肽原的一种形式。低分子量激肽原免疫吸附剂。高分子量激肽原以及低分子量激肽原的一部分具有这种校正活性,而大部分低分子量激肽原仅充当激肽释放酶的底物。因此,激肽原是Hageman因子依赖性凝血和纤维蛋白溶解的功能以及前激肽释放酶激活所必需的关键因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号